Website News and Research

RSS

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

In a recent study posted to the medRxiv*preprint server, a team of researchers from Israel developed and validated novel reverse transcriptase - quantitative polymerase chain reaction (RT-qPCR) assays. The new assays enable the rapid and high throughput identification and differentiation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 and BA.2 variants.

8 Mar 2022

Feinberg second-year medical students screen patients for food insecurity

As part of their second-year MD curriculum, a group of Feinberg students recently designed and implemented a community quality improvement project, screening patients for food insecurity at their Education-Centered Medical Home (ECMH) site, the CommunityHealth Clinic, on Chicago's West side.

7 Mar 2022

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

50-user access ideal for large hospital trusts and University/Medical School remote haematology learning activities.

4 Mar 2022

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

50-user access ideal for large hospital trusts and University/Medical School remote haematology learning activities.

4 Mar 2022

See it to Believe it: How Medical Imaging Technologies Could Help Reduce Health Risks and Inspire Behavior Change

In this interview, we speak to Dr Gareth Hollands about his latest research that investigated the use of medical imaging to reduce health risks and encourage behavior change.

4 Mar 2022

Grammar teaching in primary schools may not help children's narrative writing

The teaching of grammar in primary schools in England (a key feature of England's national curriculum) does not appear to help children's narrative writing, although it may help them generate sentences, according to new UCL-led research.

3 Mar 2022

INTEGRA’s VOYAGER offers effective pipetting for plant-based transient expression and bacteriocin testing applications

Researchers at NOMAD Bioscience GmbH are taking advantage of the remarkable liquid handling capabilities of INTEGRA’s VOYAGER adjustable tip spacing pipette for the preparation and dispensing of media and gels.

From INTEGRA Biosciences 1 Mar 2022

New portal launched to order personal protective equipment in England

A new online platform to order personal protective equipment (PPE) in England has been launched.

28 Feb 2022

Alcohol consumption may be a modifiable risk factor for age-related macular degeneration

Even though Dry January is over, new research suggests you may want to consider keeping the no-alcohol challenge going all year, especially if you're among the nearly 2 million Americans who have age-related macular degeneration (AMD), a sight-threatening eye condition.

28 Feb 2022

The epidemiology of COVID-19 in Africa

A new study uses the Africa CDC generic protocol for obtaining COVID-19 seroprevalence data to understand the spread and epidemiology of SARS-CoV-2.

27 Feb 2022

COVID babies score slightly lower on developmental screening test

In this interview, we speak to Dr. Dani Dumitriu about her latest research that investigated the development screening test scores for babies born during COVID-19.

25 Feb 2022

Why is it Important to Democratize Proteomics Data?

In this interview, we speak to Steve Kosteski from IsoPlexis about the importance of single-cell proteomics within the life sciences sector.

From Society for Laboratory Automation and Screening (SLAS) 23 Feb 2022

Targeted by politicians, trans youth struggle with growing fear and mental health concerns

Charlie Apple had experienced people calling into question his humanity, suggesting he was just a confused kid or even a moral aberration. As a transgender teen, he had accepted that his future could include discrimination, verbal abuse, and violence. The sense of peace he said he felt in transitioning physically, however, was worth the risk.

23 Feb 2022

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

On May 13 of last year, the cellphones of thousands of California residents undergoing treatment for chronic pain lit up with a terse text message: "Due to unforeseen circumstances, Lags Medical Centers will be closing effective May 19, 2021."

22 Feb 2022

Study to evaluate efficacy of higher dose of ivermectin for treating mild-to-moderate COVID-19

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University has expanded its testing platform to evaluate ivermectin at a higher dose for a longer period of time.

17 Feb 2022

How accurate are rapid antigen COVID tests?

A new study updates the state of knowledge about antigen rapid diagnostic tests (Ag-RDT) in the diagnosis of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Feb 2022

As politics infects public health, private companies profit

For some counties and cities that share a public health agency with other local governments, differences over mask mandates, business restrictions, and other covid preventive measures have strained those partnerships.

17 Feb 2022

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

The University of Cincinnati is joining a nationwide study to evaluate repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.

16 Feb 2022

INTEGRA offers tips and tricks to solve your pipetting challenges

INTEGRA Biosciences has created a series of videos to help life sciences researchers improve pipetting accuracy and precision.

From INTEGRA Biosciences 16 Feb 2022

Inside the tactical tug of war over the controversial Alzheimer’s drug

The drug industry, patient advocates, and congressional Republicans have all attacked federal officials' decision to decline routine Medicare coverage for a controversial Alzheimer's drug.

16 Feb 2022

Website News and Research

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

Feinberg second-year medical students screen patients for food insecurity

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

HORIBA introduces network option for digital morphology training tool for multiple user access in multiple locations

See it to Believe it: How Medical Imaging Technologies Could Help Reduce Health Risks and Inspire Behavior Change

Grammar teaching in primary schools may not help children's narrative writing

INTEGRA’s VOYAGER offers effective pipetting for plant-based transient expression and bacteriocin testing applications

New portal launched to order personal protective equipment in England

Alcohol consumption may be a modifiable risk factor for age-related macular degeneration

The epidemiology of COVID-19 in Africa

COVID babies score slightly lower on developmental screening test

Why is it Important to Democratize Proteomics Data?

Targeted by politicians, trans youth struggle with growing fear and mental health concerns

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

Study to evaluate efficacy of higher dose of ivermectin for treating mild-to-moderate COVID-19

How accurate are rapid antigen COVID tests?

As politics infects public health, private companies profit

UC joins nationwide trial to evaluate efficacy of repurposed drugs for mild-to-moderate COVID-19

INTEGRA offers tips and tricks to solve your pipetting challenges

Inside the tactical tug of war over the controversial Alzheimer’s drug

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News